IP Library Granted Patent US 8,343,484
Granted Patent B2
US 8,343,484 · App. 12/365,808 · Granted Jan 1, 2013

Methods for increasing lactose and fructose digestion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,343,484
App. No.
12/365,808
Granted
Jan 1, 2013
Kind
B2
Abstract

The invention relates generally to digestive disorders, and in particular to methods for treating irritable bowel syndrome by increasing carbohydrate absorption by administering a composition containing a Bacillus coagulans bacterium.

Claims (11)

1. A method for increasing carbohydrate absorption in a mammal, comprising the steps of:

identifying a mammal having a symptom of carbohydrate malabsorption, and

orally administering to said mammal a composition comprising an effective amount of viable Bacillus coagulans bacteria, an effective amount of a supplementary lactase to increase lactose digestion in said mammal, and an effective amount of a supplementary fructase, an enzyme that catalyzes the hydrolysis of fructose, to increase fructose digestion in said mammal,

wherein said Bacillus coagulans bacteria are selected from the group consisting of GBI-20, ATCC PTA-6085; GBI-30, ATCC PTA-6086; and GBI-40, ATCC PTA-6087, and

wherein carbohydrate absorption is increased following said administration.

2. The method of claim 1 , wherein said symptom of carbohydrate malabsorption is selected from the group consisting of lactose intolerance, fructose intolerance, glucose-galactose intolerance and sorbitol intolerance.

3. The method of claim 1 , wherein the mammal is human.

4. The method of claim 1 , wherein said effective amount of lactase is from about 1000 IU to about 12,000 IU and wherein said effective amount of fructase is from about 1000 IU to about 12,000 IU.

5. The method of claim 1 , wherein said composition further comprises one or more components selected from the group consisting of an anti-diarrheal agent, an anti-gas agent, a laxative, a vitamin, a mineral, an isolated amino acid, a source of dietary fiber, and an antibiotic.

6. The method of claim 1 , wherein said composition is in the form of a capsule, a tablet, a powder, a liquid, or a food product.

7. The method of claim 1 , wherein said composition is administered once per day.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2017
From: SILICON VALLEY BANK
To: GANEDEN BIOTECH, INC.
Reel/Frame 043822/0897 →
SECURITY AGREEMENT Recorded Oct 10, 2012
From: GANEDEN BIOTECH, INC.
To: SILICON VALLEY BANK
Reel/Frame 029103/0069 →
LICENSE Recorded Jul 19, 2011
From: GANEDEN BIOTECH, INC.
To: SCHIFF NUTRITION GROUP, INC.
Reel/Frame 026616/0128 →
SECURITY AGREEMENT Recorded Jul 19, 2011
From: GANEDEN BIOTECH, INC.
To: SCHIFF NUTRITION GROUP, INC.
Reel/Frame 026616/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2009
From: FARMER, SEAN; LEFKOWITZ, ANDREW R.
To: GANEDEN BIOTECH, INC.
Reel/Frame 022226/0687 →